Suboccipital Inhibition in Tension Headache

Tension Headache Clinical Trial

Official title:

Suboccipital Inhibition in Tension Headache

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT04376125
• Other study ID #: 71441538L
• Status: Enrolling by invitation
• Phase: N/A
• Start date: February 1, 2019
• Est. completion date: June 30, 2020

Study information

• Verified date: May 2020
• Source: Universidad de León
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The researchers will carry out a randomized experimental study. Participants in the experimental group will receive a treatment based on suboccipital inhibition technique in addition to conventional treatment. Participants in the control group will only receive the conventional treatment. The existence of significant differences in both groups will be analyzed.

Description:

Conventional therapy will consist of microwaves, interference currents, and manual therapy.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 30
• Est. completion date: June 30, 2020
• Est. primary completion date: November 22, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• pathology tension headache associated with cervicalgia

Exclusion Criteria:

• pathology of nervous system

Related Conditions & MeSH terms

• Headache
• Tension Headache
• Tension-Type Headache

Intervention

Other:
• Suboccipital inhibition in tension headache
Deep maneuver of myofascial induction in the suboccipital muscles

Locations

Country	Name	City	State
Spain	Cristina Blanco Ortega	León

Sponsors (2)

Lead Sponsor	Collaborator
Universidad de León	SACyL

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Visual Analogue Scale for Pain	a continuous scale comprised of a horizontal (HVAS) or vertical (VVAS) line, usually 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extreme: "no pain" (score of 0) and "worst imaginable pain" (score of 10)	immediately before starting the intervention and after the last session of the intervention, that is, 2 weeks from the start
Secondary	Change in Six-item Headache Impact Text	A global measure of adverse headache impact. The final HIT-6 score is obtained from simple summation of the six items and ranges between 36 and 78, with larger scores reflecting greater impact.	immediately before starting the intervention and after the last session of the intervention, that is, 2 weeks from the start